Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy

Implications for potential use of inhibitors in cancer treatment

Linda M. Johnson Molecular Pharmacology Section; Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA

Douglas K. Price Molecular Pharmacology Section; Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA

William D Figg Molecular Pharmacology Section; Medical Oncology Branch; National Cancer Institute; Bethesda, MD USA; Clinical Pharmacology Section; Medical Oncology Branch; National Cancer Institute; Bethesda, MD USACorrespondence[email protected]

References

Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol 2005; 205:275 - 92; http://dx.doi.org/10.1002/path.1706; PMID: 15641020
PubMed Web of Science ®Google Scholar
Kerbel RS, Kobayashi H, Graham CH. Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes?. J Cell Biochem 1994; 56:37 - 47; http://dx.doi.org/10.1002/jcb.240560108; PMID: 7806590
PubMed Web of Science ®Google Scholar
Davis AJ, Tannock JF. Repopulation of tumour cells between cycles of chemotherapy: a neglected factor. Lancet Oncol 2000; 1:86 - 93; http://dx.doi.org/10.1016/S1470-2045(00)00019-X; PMID: 11905673
PubMedGoogle Scholar
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 2012; http://dx.doi.org/10.1038/nm2890; PMID: 22863786
PubMed Web of Science ®Google Scholar
Binet R, Ythier D, Robles AI, Collado M, Larrieu D, Fonti C, et al. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res 2009; 69:9183 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-09-1016; PMID: 19951988
PubMed Web of Science ®Google Scholar
Fear MW, Kelsell DP, Spurr NK, Barnes MR. Wnt-16a, a novel Wnt-16 isoform, which shows differential expression in adult human tissues. Biochem Biophys Res Commun 2000; 278:814 - 20; http://dx.doi.org/10.1006/bbrc.2000.3852; PMID: 11095990
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy

Implications for potential use of inhibitors in cancer treatment

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy

Implications for potential use of inhibitors in cancer treatment

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date